Medytox saw the highest growth of 3.99% in patent filings and 4.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Medytox’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Medytox has been focused on protecting inventions in European Patent Office(EPO) with eight publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 43% filings and 17% grants. The European Patent Office(EPO), Japan(JP), South Korea(KR), and China(CN) patent Office are among the top ten patent offices where Medytox is filings its patents. Among the top granted patent authorities, Medytox has 33% of its grants in Japan(JP), 17% in European Patent Office(EPO) and 17% in China(CN).
AbbVie and Revance Therapeutics could be the strongest competitors for Medytox
In terms of grant share, Medytox stands in fourth position among its competitors. AbbVie and Revance Therapeutics secured the top positions according to recent patent publication data.
Patents related to climate change and cell & gene therapy lead Medytox's portfolio
Medytox has the highest number of patents in climate change followed by, cell & gene therapy and health & wellness. For climate change, nearly 50% of patents were filed and 33% of patents were granted in Q2 2024.
Petrochemicals related patents lead Medytox portfolio followed by skincare, and anti-agers
Medytox has highest number of patents in petrochemicals followed by skincare, anti-agers, cosmetics & toiletries, and edema. For petrochemicals, nearly 29% of patents were filed and 5% of patents were granted in Q2 2024.
For comprehensive analysis of Medytox's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
